Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06315140 · ClinicalTrials.gov registry record · NA

Assessing and Addressing Community Exposures to Environmental Contaminants

A NA study of Environmental Exposure, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT06315140: Recruiting NA study of Environmental Exposure, sponsored by NYU Langone Health.

NCT06315140 is a NA study of Environmental Exposure that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 400 participants, above the 259-participant average among 13 other Environmental Exposure trials with a reported enrollment target (54% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06315140, a NA study of Environmental Exposure, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to build on our equitable, eight-year Tribal-academic partnership with the Ramapough Nation of northern NJ to advance tradition-centered farming practices and management strategies supporting sustainable food systems to relieve local food insecurity and nutritional deficiency, prevent disease and promote health. Furthermore, assessing the extent of environmental contamination, individual toxicant burdens and micronutrient levels and health disorders in Ramapough Tribal members of both sexes as outlined in the following: * Collect in-person/online survey information on demographics, health and food intake, nutrition, food security, and psychosocial stressors, and perform core anthropometric measurements (i.e., height, weight, body mass index, body circumference and blood pressure) at enrollment on Tribal members to inform health promotion strategies and community actions. * Determine individual-level contaminant burdens and micronutrient concentrations (e.g., iron, calcium, folate, vitamins) in urine and blood from surveyed (sub-aim 1a) Ramapough Turtle Clan volunteers. * Test soil, plants and surface water where Turtle Clan residents live, recreate and attend church in Ringwood, NJ using a community-based, citizen scientist approach.

Primary Outcome

Outcome measures will be collected using home water samples.

Conditions Studied

Interventions

  • OTHER Nutrition

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2023-02-16
Est. Completion 2027-04
Phase NA
NYU Langone Health

1,164 total trials

What NCT06315140 shows while recruiting

NCT06315140 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 259-participant average among 13 other Environmental Exposure trials with a reported enrollment target (54% higher).

The record links to 1 condition, with Environmental Exposure appearing as the primary indexed condition, and to 1 intervention - of which Nutrition is the first listed.

NCT06315140 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06315140 about?

NCT06315140 is a clinical study titled "Assessing and Addressing Community Exposures to Environmental Contaminants". The purpose of this study is to build on our equitable, eight-year Tribal-academic partnership with the Ramapough Nation of northern NJ to advance tradition-centered farming practices and management strategies supporting sustainable food systems to relieve local food insecurity and nutritional defic...

What is the current status of trial NCT06315140?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2023-02-16. Estimated completion is 2027-04.

What conditions does trial NCT06315140 study?

This clinical trial studies the following conditions: Environmental Exposure.

What interventions are being tested in trial NCT06315140?

The interventions under investigation include: Nutrition (OTHER).

Who is sponsoring clinical trial NCT06315140?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06315140 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Environmental Exposure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06315140's enrollment target sits among peer trials

400 4th of 13 higher than 10 of 13 other Environmental Exposure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Environmental Exposure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06315140, the US trial registry maintained by the National Library of Medicine. NCT06315140 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.